Simple and sensitive LC-MS/MS-based assay for the quantification of dimemorfan in human plasma for use in a pharmacokinetic study
Dimemorfan phosphate has been widely used for 40 years throughout the world for the treatment of coughs. This is the first report on the use of an LC‐MS/MS‐based assay for the determination of dimemorfan in human plasma using estazolam as an internal standard after one‐step protein precipitation wit...
Saved in:
| Published in | Biomedical chromatography Vol. 29; no. 5; pp. 647 - 653 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Blackwell Publishing Ltd
01.05.2015
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0269-3879 1099-0801 1099-0801 |
| DOI | 10.1002/bmc.3325 |
Cover
| Summary: | Dimemorfan phosphate has been widely used for 40 years throughout the world for the treatment of coughs. This is the first report on the use of an LC‐MS/MS‐based assay for the determination of dimemorfan in human plasma using estazolam as an internal standard after one‐step protein precipitation with acetonitrile. Chromatographic separation was achieved on a Phenomenex Luna C18 column (3 µm, 50 × 2.0 mm) using a fast gradient method, which involves water and methanol as the mobile phase (both containing 0.1% formic acid). Dimemorfan and estazolam were detected with proton adducts at m/z values of 255.8 → 155.1 and 295.0 → 267.0, respectively, in the selected reaction monitoring positive mode. The linear dynamic range of the assay was 0.04–5.00 ng/mL. The chromatographic run time for each plasma sample was <5 min. The method was proven to be accurate, precise, and repeatable. Finally, the developed method was successfully applied for the determination of dimemorfan in a pharmacokinetic study using healthy Chinese subjects. Copyright © 2014 John Wiley & Sons, Ltd. |
|---|---|
| Bibliography: | National Scientific Foundation of China - No. 81373476, 81302851 and 81301924 National Science and Technology Major Projects for 'Major New Drugs Innovation and Development' - No. 2012ZX09303014-001 ark:/67375/WNG-5X9M5BLB-F Health Department Foundation of Hunan Province - No. 132013-028 Program for Science and Technology Research of Hunan Province - No. 2012WK3044 istex:92641372588EC37853780170EF04352BB5133FA4 ArticleID:BMC3325 The first two authors contributed equally to this work. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
| ISSN: | 0269-3879 1099-0801 1099-0801 |
| DOI: | 10.1002/bmc.3325 |